US Department of Veterans Affairs: Schizophrenia trials

The registry lists 27 Schizophrenia studies with US Department of Veterans Affairs as lead sponsor. 0 are open to participants now and 11 have results posted.

Phase 2 2Phase 3 2Phase 4 3No phase 21(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• fMRI Cholinergic Mechanisms in SchizophreniaCompletedNCT01191827Results posted
• Smoking Cessation for Veterans With Severe and Persistent Mental IllnessCompletedNCT00960375Phase 2/3Results posted
• Mindfulness Meditation as a Rehabilitation Strategy for Persons With SchizophreniaCompletedNCT00936351Not applicableResults posted
• Functional Rehabilitation for Older Patients With SchizophreniaTerminatedNCT00712075Not applicableResults posted
• A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs)CompletedNCT00677898Not applicableResults posted
• The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.CompletedNCT00466323Not applicableResults posted
• Predictors of Response to Cognitive Remediation in SchizophreniaCompletedNCT00333970Not applicableResults posted
• Functional Rehabilitation of Older Patients With SchizophreniaCompletedNCT00237796Not applicableResults posted
• Patient-Centered Medication Adherence Intervention for SchizophreniaCompletedNCT00144027Not applicableResults posted
• A Brief Community Linkage Intervention for Dually Diagnosed IndividualsCompletedNCT00137267Not applicableResults posted
• Long-Acting Injectable Risperidone in the Treatment of SchizophreniaCompletedNCT00132314Phase 3Results posted
• CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar IllnessCompletedNCT01149551
• Cognitive Remediation for SchizophreniaCompletedNCT00261794Not applicable
• A Study of Strategies to Improve Schizophrenia TreatmentCompletedNCT00156637Not applicable
• Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)CompletedNCT00119574Not applicable
• The Effects of Risperidone and Olanzapine on ThinkingCompletedNCT00108368Phase 4
• Generalization of Training in SchizophreniaCompletedNCT00108199Not applicable
• Psychiatric Advance Directives for Improved Mental Health CareCompletedNCT00105794Not applicable
• Improving Antipsychotic Adherence Among Patients With Serious Mental IllnessCompletedNCT00057135Not applicable
• 5HT3 Antagonism and Auditory Gating in SchizophreniaCompletedNCT00018850Not applicable
• Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment OutcomeCompletedNCT00018837Not applicable
• Antipsychotic Response in SchizophreniaCompletedNCT00018668Phase 4
• Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00018642Not applicable
• Cognitive - Behavioral TherapyCompletedNCT00018629Phase 2
• A Multi-Site Study of Strategies for Implementing Schizophrenia GuidelinesCompletedNCT00013000Not applicable
• Improving Health Services for Veterans With SchizophreniaCompletedNCT00012961
• To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of SchizophreniaCompletedNCT00007774Phase 4